Список литературы к Главе 22

1. Hallek M. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines // Blood. 2008. Vol. 111, N 12. P. 5446–5456.

2. Swerdlow S.H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms // Blood. 2016. Vol. 127, N 20. P. 2375–2390.

3. Rawstron A.C. et al. Monoclonal B lymphocytes with the characteristics of «indolent» chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts // Blood. 2002. Vol. 100, N 2. P. 635–649.

4. Ghia P. et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly // Blood. 2004. Vol. 103, N 6. P. 2337–2342.

5. Rawstron A.C. et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia // N. Engl. J. Med. 2008. Vol. 359, N 6. P. 575-583.

6. Nieto W.G. et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach // Blood. 2009. Vol. 114, N 1. P. 33–37.

7. Call T.G. et al. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines // Cancer. 2014. Vol. 120, N 13. P. 2000–2005.

8. Vogt R.F. et al. Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies // Br. J. Haematol. 2007. Vol. 139, N 5. P. 690–700.

9. Shim Y.K. et al. Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population // Cytometry B Clin. Cytom. 2007. Vol. 72, N 5. P. 344–353.

10. Landgren O. et al. B-cell clones as early markers for chronic lymphocytic leukemia // N. Engl. J. Med. 2009. Vol. 360, N 7. P. 659–667.

11. Scarfò L. et al. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? // Semin. Cancer Biol. 2010. Vol. 20, N 6. P. 384–390.

12. Slager S.L. et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL // Blood. 2011. Vol. 117, N 6. P. 1911–1916.

13. Muscara M.J. et al. Establishing absolute lymphocyte count thresholds for further review of peripheral blood lymphocytosis to judiciously screen for monoclonal B-cell populations in older adults // Am. J. Clin. Pathol. 2019. Vol. 152, N 4. P. 458–462.

14. Rawstron A.C. et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL) // Cytometry B Clin. Cytom. 2010. Vol. 78, suppl. 1. P. S19–S23.

15. Goldin L.R. et al. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families // Br. J. Haematol. 2010. Vol. 151, N 2. P. 152–158.

16. Matos D.M. et al. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia // Br. J. Haematol. 2009. Vol. 147, N 3. P. 339–346.

17. Crowther-Swanepoel D. et al. Inherited genetic susceptibility to monoclonal B-cell lymphocytosis // Blood. 2010. Vol. 116, N 26. P. 5957-5960.

18. Sellick G.S. et al. A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia // Blood. 2007. Vol. 110, N 9. P. 3326–3333.

19. Strati P., Shanafelt T.D. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification // Blood. 2015. Vol. 126, N 4. P. 454–462.

20. Fazi C. et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals // Cytometry B Clin. Cytom. 2010. Vol. 78, suppl. 1. P. S61–S68.

21. Anderson L.A., Landgren O., Engels E.A. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia // Br. J. Haematol. 2009. Vol. 147, N 4. P. 444–449.

22. Casabonne D. et al. Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults // PLoS One. 2012. Vol. 7, N 12. Article ID e52808.

23. Scarfò L., Fazi C., Ghia P. MBL versus CLL: how important is the distinction? // Hematol. Oncol. Clin. North Am. 2013. Vol. 27, N 2. P. 251–265.

24. Parikh S.A., Kay N.E., Shanafelt T.D. Monoclonal B-cell lymphocytosis: update on diagnosis, clinical outcome, and counseling // Clin. Adv. Hematol. Oncol. 2013. Vol. 11, N 11. P. 720–729.

25. Dagklis A. et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring // Blood. 2009. Vol. 114, N 1. P. 26–32.

26. Shanafelt T.D. et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia // J. Clin. Oncol. 2009. 27(24): p. 3959-63.

27. Fung S.S. et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis // Leuk. Lymphoma. 2007. Vol. 48, N 6. P. 1087–1091.

28. Fazi C. et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL // Blood. 2011. Vol. 118, N 25. P. 6618–6625.

29. Shanafelt T.D. et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management // Leukemia. 2010. Vol. 24, N 3. P. 512–520.

30. Shanafelt T., Hanson C.A. Monoclonal B-cell lymphocytosis: definitions and natural history // Leuk. Lymphoma. 2009. Vol. 50, N 3. P. 493–497.

31. Scarfò L. et al. Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? // Leukemia. 2012. Vol. 26, N 7. P. 1703–1707.

32. Barrio S. et al. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome // Leukemia. 2017. Vol. 31, N 1. P. 170–176.

33. Rossi D. et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors // Br. J. Haematol. 2009. Vol. 146, N 1. P. 64–75.

34. Kern W. et al. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL // Br. J. Haematol. 2012. Vol. 157, N 1. P. 86–96.

35. Shanafelt T.D. et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome // Blood. 2009. Vol. 113, N 18. P. 4188–4196.

36. Maitre E., Troussard X. Monoclonal B-cell lymphocytosis // Best Pract. Res. Clin. Haematol. 2019. Vol. 32, N 3. P. 229–238.

37. Rossi D. et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors // Br. J. Haematol. 2009. Vol. 146, N 1. P. 64–75.

38. Lanasa M.C. et al. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL // Leukemia. 2011. Vol. 25, N 9. P. 1459–1466.

39. Gibson S.E. et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis // Haematologica. 2011. Vol. 96, N 8. P. 1144–1152.

40. Ghia P. Another piece of the puzzle: is there a «nodal» monoclonal B-cell lymphocytosis? // Haematologica. 2011. Vol. 96, N 8. P. 1089–1091.

41. Berkowska M.A. et al. Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+Ig- M+IgD+ memory B cells with a distinctive immunophenotype // Leukemia. 2014. Vol. 28, N 7. P. 1560–1564.

42. Moreira J. et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls // Leukemia. 2013. Vol. 27, N 1. P. 136–141.

43. Kay N.E. Abnormal T-cell subpopulation function in CLL: excessive suppressor (Tγ) and deficient helper (Tµ) activity with respect to B-cell proliferation // Blood. 1981. Vol. 57, N 3. P. 418–420.

44. te Raa G.D. et al. Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis // Leuk. Lymphoma. 2012. Vol. 53, N 11. P. 2321–2325.

45. Zeya H.I. et al. Monocyte and granulocyte defect in chronic lymphocytic leukemia // Am. J. Pathol. 1979. Vol. 95, N 1. P. 43–54.

46. Parikh S.A. et al. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis // Haematologica. 2018. Vol. 103, N 6. P. e237–e240.

47. Sánchez-Ramón S., Dhalla F., Chapel H. Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy // Front. Immunol. 2016. Vol. 7. P. 317.

48. Solomon. B.M. et al. Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis // Leukemia. 2016. Vol. 30, N 2. P. 331–336.

49. Mittal S. et al. A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura // Haematologica. 2008. Vol. 93, N 1. P. 151–152.

50. Strati P. et al. Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience // Haematologica. 2015. Vol. 100, N 9. P. 1180–1188.

51. Htet Z.M. et al. Multiple faces of chronic lymphocytic leukaemia: a patient with renal, cardiac, and skeletal complications // Case Rep. Nephrol. 2019. Vol. 2019. Article ID 5390235.

52. Ratterman M. et al. Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012 // Leuk. Res. 2014. Vol. 38, N 3. P. 299–303.

53. Phillips J.K. et al. Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia // J. Clin. Pathol. 1993. Vol. 46, N 12. P. 1131–1133.

54. Wanchoo R. et al. Renal involvement in chronic lymphocytic leukemia // Clin. Kidney J. 2018. Vol. 11, N 5. P. 670–680.

55. Wynsberghe M.V. et al. Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance? // J. Nephrol. 2018. Vol. 31, N 2. P. 317–320.

56. Nieto W.G. et al. Commentary: comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection // Cytometry B Clin. Cytom. 2010. Vol. 78, suppl. 1. P. S4–S9.

57. Nieto W.G. et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach // Blood. 2009. Vol. 114, N 1. P. 33–37.

58. Vardi A. et al. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL // Blood. 2013. Vol. 121, N 22. P. 4521–4528.

59. Fazi C. et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL // Blood. 2011. Vol. 118, N 25. P. 6618–6625.

60. Agathangelidis A. et al. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations // Haematologica. 2018. Vol. 103, N 5. P. 865–873.

61. Agathangelidis A. et al. High-throughput analysis of the T cell receptor gene repertoire in low-count monoclonal B cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia // Haematologica. 2020. Vol. 105, N 10. Article ID 221275.

62. Criado I. et al. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome // Haematologica. 2018. Vol. 103, N 7. P. 1198–1208.

63. Shim Y.K. et al. Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding // Blood. 2014. Vol. 123, N 9. P. 1319–1326.